CBI logo

Clal Biotechnology Industries Ltd. Stock Price

TASE:CBI Community·₪46.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CBI Share Price Performance

₪0.29
-0.06 (-17.00%)
₪0.29
-0.06 (-17.00%)
Price ₪0.29

CBI Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk and slightly overvalued.

4 Risks
0 Rewards

Clal Biotechnology Industries Ltd. Key Details

₪0

Revenue

₪0

Cost of Revenue

₪0

Gross Profit

₪31.5m

Other Expenses

-₪31.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.20
0%
0%
52.9%
View Full Analysis

About CBI

Founded
1998
Employees
n/a
CEO
Avraham Fischer
WebsiteView website
www.cbi.co.il

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel. It operates as a former subsidiary of Clal Industries and Investments Ltd.

Recent CBI News & Updates

Would Clal Biotechnology Industries (TLV:CBI) Be Better Off With Less Debt?

Sep 08
Would Clal Biotechnology Industries (TLV:CBI) Be Better Off With Less Debt?

Recent updates

No updates